Results of care registry released with new TAVR national coverage determination on the hor ...

A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...

Doctors at VishwaRaj Hospital successfully treated a 75-year-old patient with severe aortic valve stenosis using Transcatheter Aortic Valve Replacement (TAVR), a minimally invasive alternative to open ...

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

Thubrikar Aortic Valve, Inc. today announced its partnership with MAC's MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC's CEO, Ante Cicin-Sain. As part of the exclusive distr ...

Primary results of the ENCIRCLE trial led to approval of the M3 device by the US Food and Drug Administration as the first ...

According to a medical report seen by The Point and signed by Dr. Emon Majdabadi of the Medical Research Council (MRC) Unit ...

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart ...

BACKGROUND: Undertreatment and delayed treatment of aortic stenosis (AS) are common, both of which are associated with increased mortality. Historically, assessment of quality for AS care has focused ...

The Optimum TAVI system has been named “Top Aortic Valve Implantation System 2026” by the publication MED TECH Outlook. A detailed interview of Dr. Thubrikar, author of the 1991 textbook “The Aortic ...

In severe disease of the aortic valve, choosing a new heart valve is especially difficult for young women who want to become pregnant.

Medtronic's asset quality is high, but strategic diffusion and slow growth hinder valuation. Click here to read why MDT stock ...